Post-translational modification

  (Redirected from Posttranslational modification)

Post-translational modification (PTM) is the covalent and generally enzymatic modification of proteins following protein biosynthesis. This process occurs in the endoplasmic reticulum and the golgi apparatus.[1] Proteins are synthesized by ribosomes translating mRNA into polypeptide chains, which may then undergo PTM to form the mature protein product. PTMs are important components in cell signaling, as for example when prohormones are converted to hormones.

Post-translational modification of insulin. At the top, the ribosome translates a mRNA sequence into a protein, insulin, and passes the protein through the endoplasmic reticulum, where it is cut, folded, and held in shape by disulfide (-S-S-) bonds. Then the protein passes through the golgi apparatus, where it is packaged into a vesicle. In the vesicle, more parts are cut off, and it turns into mature insulin.

Post-translational modifications can occur on the amino acid side chains or at the protein's C- or N- termini.[2] They can extend the chemical repertoire of the 20 standard amino acids by modifying an existing functional group or introducing a new one such as phosphate. Phosphorylation is a very common mechanism for regulating the activity of enzymes and is the most common post-translational modification.[3] Many eukaryotic and prokaryotic proteins also have carbohydrate molecules attached to them in a process called glycosylation, which can promote protein folding and improve stability as well as serving regulatory functions. Attachment of lipid molecules, known as lipidation, often targets a protein or part of a protein attached to the cell membrane.

Other forms of post-translational modification consist of cleaving peptide bonds, as in processing a propeptide to a mature form or removing the initiator methionine residue. The formation of disulfide bonds from cysteine residues may also be referred to as a post-translational modification.[4] For instance, the peptide hormone insulin is cut twice after disulfide bonds are formed, and a propeptide is removed from the middle of the chain; the resulting protein consists of two polypeptide chains connected by disulfide bonds.

Some types of post-translational modification are consequences of oxidative stress. Carbonylation is one example that targets the modified protein for degradation and can result in the formation of protein aggregates.[5][6] Specific amino acid modifications can be used as biomarkers indicating oxidative damage.[7]

Sites that often undergo post-translational modification are those that have a functional group that can serve as a nucleophile in the reaction: the hydroxyl groups of serine, threonine, and tyrosine; the amine forms of lysine, arginine, and histidine; the thiolate anion of cysteine; the carboxylates of aspartate and glutamate; and the N- and C-termini. In addition, although the amide of asparagine is a weak nucleophile, it can serve as an attachment point for glycans. Rarer modifications can occur at oxidized methionines and at some methylene groups in side chains.[8]

Post-translational modification of proteins can be experimentally detected by a variety of techniques, including mass spectrometry, Eastern blotting, and Western blotting. Additional methods are provided in the #External links section.

PTMs involving addition of functional groupsEdit

Addition by an enzyme in vivoEdit

Hydrophobic groups for membrane localizationEdit

Cofactors for enhanced enzymatic activityEdit

Modifications of translation factorsEdit

Smaller chemical groupsEdit

Non-enzymatic additions in vivoEdit

Non-enzymatic additions in vitroEdit

  • biotinylation: covalent attachment of a biotin moiety using a biotinylation reagent, typically for the purpose of labeling a protein.
  • carbamylation: the addition of Isocyanic acid to a protein's N-terminus or the side-chain of Lys or Cys residues, typically resulting from exposure to urea solutions.[18]
  • oxidation: addition of one or more Oxygen atoms to a susceptible side-chain, principally of Met, Trp, His or Cys residues. Formation of disulfide bonds between Cys residues.
  • pegylation: covalent attachment of polyethylene glycol (PEG) using a pegylation reagent, typically to the N-terminus or the side-chains of Lys residues. Pegylation is used to improve the efficacy of protein pharmaceuticals.

Conjugation with other proteins or peptidesEdit

Chemical modification of amino acidsEdit

Structural changesEdit

StatisticsEdit

Common PTMs by frequencyEdit

In 2011, statistics of each post-translational modification experimentally and putatively detected have been compiled using proteome-wide information from the Swiss-Prot database.[23] The 10 most common experimentally found modifications were as follows:[24]

Frequency Modification
58383 Phosphorylation
6751 Acetylation
5526 N-linked glycosylation
2844 Amidation
1619 Hydroxylation
1523 Methylation
1133 O-linked glycosylation
878 Ubiquitylation
826 Pyrrolidone carboxylic acid
504 Sulfation

Common PTMs by residueEdit

Some common post-translational modifications to specific amino-acid residues are shown below. Modifications occur on the side-chain unless indicated otherwise.

Amino Acid Abbrev. Modification
Alanine Ala N-acetylation (N-terminus)
Arginine Arg deimination to citrulline, methylation
Asparagine Asn deamidation to Asp or iso(Asp), N-linked glycosylation
Aspartic acid Asp isomerization to isoaspartic acid
Cysteine Cys disulfide-bond formation, oxidation to sulfenic, sulfinic or sulfonic acid, palmitoylation, N-acetylation (N-terminus), S-nitrosylation
Glutamine Gln cyclization to pyroglutamic acid (N-terminus), deamidation to Glutamic acid or isopeptide bond formation to a lysine by a transglutaminase
Glutamic acid Glu cyclization to Pyroglutamic acid (N-terminus), gamma-carboxylation
Glycine Gly N-Myristoylation (N-terminus), N-acetylation (N-terminus)
Histidine His Phosphorylation
Isoleucine Ile
Leucine Leu
Lysine Lys acetylation, ubiquitylation, SUMOylation, methylation, hydroxylation
Methionine Met N-acetylation (N-terminus), N-linked Ubiquitination, oxidation to sulfoxide or sulfone
Phenylalanine Phe
Proline Pro hydroxylation
Serine Ser Phosphorylation, O-linked glycosylation, N-acetylation (N-terminus)
Threonine Thr Phosphorylation, O-linked glycosylation, N-acetylation (N-terminus)
Tryptophan Trp mono- or di-oxidation, formation of kynurenine, tryptophan tryptophylquinone
Tyrosine Tyr sulfation, phosphorylation
Valine Val N-acetylation (N-terminus)

Databases and toolsEdit

 
Flowchart of the process and the data sources to predict PTMs.[25]

Protein sequences contain sequence motifs that are recognized by modifying enzymes, and which can be documented or predicted in PTM databases. With the large number of different modifications being discovered, there is a need to document this sort of information in databases. PTM information can be collected through experimental means or predicted from high-quality, manually curated data. Numerous databases have been created, often with a focus on certain taxonomic groups (e.g. human proteins) or other features.

List of resourcesEdit

  • PhosphoSitePlus[26] – A database of comprehensive information and tools for the study of mammalian protein post-translational modification
  • ProteomeScout[27] – A database of proteins and post-translational modifications experimentally
  • Human Protein Reference Database[27] – A database for different modifications and understand different proteins, their class, and function/process related to disease causing proteins
  • PROSITE[28] – A database of Consensus patterns for many types of PTM's including sites
  • Protein Information Resource (PIR)[29] – A database to acquire a collection of annotations and structures for PTMs.
  • dbPTM[25] – A database that shows different PTM's and information regarding their chemical components/structures and a frequency for amino acid modified site
  • Uniprot has PTM information although that may be less comprehensive than in more specialized databases.
     
    Effect of PTMs on protein function and physiological processes.[30]
  • The O-GlcNAc Database[31][32] - A curated database for protein O-GlcNAcylation and referencing more than 14 000 protein entries and 10 000 O-GlcNAc sites.

ToolsEdit

List of software for visualization of proteins and their PTMs

  • PyMOL[33] – introduce a set of common PTM's into protein models
  • AWESOME[34] – Interactive tool to see the role of single nucleotide polymorphisms to PTM's
  • Chimera[35] – Interactive Database to visualize molecules

Case examplesEdit

See alsoEdit

ReferencesEdit

  1. ^ "Post Translational Modification Of Proteins - Translation". Jack Westin. 26 February 2020. Retrieved 9 June 2022.{{cite web}}: CS1 maint: url-status (link)
  2. ^ Pratt, Charlotte W.; Voet, Judith G.; Voet, Donald (2006). Fundamentals of Biochemistry: Life at the Molecular Level (2nd ed.). Hoboken, NJ: Wiley. ISBN 9780471214953. OCLC 1280801548. Archived from the original on 13 July 2012.
  3. ^ Khoury GA, Baliban RC, Floudas CA (September 2011). "Proteome-wide post-translational modification statistics: frequency analysis and curation of the swiss-prot database". Scientific Reports. 1: 90. Bibcode:2011NatSR...1E..90K. doi:10.1038/srep00090. PMC 3201773. PMID 22034591.
  4. ^ Lodish H, Berk A, Zipursky SL, et al. (2000). "17.6, Post-Translational Modifications and Quality Control in the Rough ER". Molecular Cell Biology (4th ed.). New York: W. H. Freeman. ISBN 978-0-7167-3136-8.
  5. ^ Dalle-Donne I, Aldini G, Carini M, Colombo R, Rossi R, Milzani A (2006). "Protein carbonylation, cellular dysfunction, and disease progression". Journal of Cellular and Molecular Medicine. 10 (2): 389–406. doi:10.1111/j.1582-4934.2006.tb00407.x. PMC 3933129. PMID 16796807.
  6. ^ Grimsrud PA, Xie H, Griffin TJ, Bernlohr DA (August 2008). "Oxidative stress and covalent modification of protein with bioactive aldehydes". The Journal of Biological Chemistry. 283 (32): 21837–41. doi:10.1074/jbc.R700019200. PMC 2494933. PMID 18445586.
  7. ^ Gianazza E, Crawford J, Miller I (July 2007). "Detecting oxidative post-translational modifications in proteins". Amino Acids. 33 (1): 51–6. doi:10.1007/s00726-006-0410-2. PMID 17021655. S2CID 23819101.
  8. ^ Walsh, Christopher T. (2006). Posttranslational modification of proteins : expanding nature's inventory. Englewood: Roberts and Co. Publ. ISBN 9780974707730. : 12–14 
  9. ^ Whiteheart SW, Shenbagamurthi P, Chen L, Cotter RJ, Hart GW, et al. (August 1989). "Murine elongation factor 1 alpha (EF-1 alpha) is posttranslationally modified by novel amide-linked ethanolamine-phosphoglycerol moieties. Addition of ethanolamine-phosphoglycerol to specific glutamic acid residues on EF-1 alpha". The Journal of Biological Chemistry. 264 (24): 14334–41. doi:10.1016/S0021-9258(18)71682-7. PMID 2569467.
  10. ^ Roy H, Zou SB, Bullwinkle TJ, Wolfe BS, Gilreath MS, Forsyth CJ, Navarre WW, Ibba M (August 2011). "The tRNA synthetase paralog PoxA modifies elongation factor-P with (R)-β-lysine". Nature Chemical Biology. 7 (10): 667–9. doi:10.1038/nchembio.632. PMC 3177975. PMID 21841797.
  11. ^ Ali, Ibraheem; Conrad, Ryan J.; Verdin, Eric; Ott, Melanie (2018). "Lysine Acetylation Goes Global: From Epigenetics to Metabolism and Therapeutics". Chemical Reviews. 118 (3): 1216–1252. doi:10.1021/acs.chemrev.7b00181. PMC 6609103. PMID 29405707.
  12. ^ Bradbury AF, Smyth DG (March 1991). "Peptide amidation". Trends in Biochemical Sciences. 16 (3): 112–5. doi:10.1016/0968-0004(91)90044-v. PMID 2057999.
  13. ^ Eddé B, Rossier J, Le Caer JP, Desbruyères E, Gros F, Denoulet P (January 1990). "Posttranslational glutamylation of alpha-tubulin". Science. 247 (4938): 83–5. Bibcode:1990Sci...247...83E. doi:10.1126/science.1967194. PMID 1967194.
  14. ^ Walker CS, Shetty RP, Clark K, Kazuko SG, Letsou A, Olivera BM, Bandyopadhyay PK, et al. (March 2001). "On a potential global role for vitamin K-dependent gamma-carboxylation in animal systems. Evidence for a gamma-glutamyl carboxylase in Drosophila". The Journal of Biological Chemistry. 276 (11): 7769–74. doi:10.1074/jbc.M009576200. PMID 11110799.
  15. ^ a b c Chung HS, et al. (January 2013). "Cysteine oxidative posttranslational modifications: emerging regulation in the cardiovascular system". Circulation Research. 112 (2): 382–92. doi:10.1161/CIRCRESAHA.112.268680. PMC 4340704. PMID 23329793.
  16. ^ Jaisson S, Pietrement C, Gillery P (November 2011). "Carbamylation-derived products: bioactive compounds and potential biomarkers in chronic renal failure and atherosclerosis". Clinical Chemistry. 57 (11): 1499–505. doi:10.1373/clinchem.2011.163188. PMID 21768218.
  17. ^ Kang HJ, Baker EN (April 2011). "Intramolecular isopeptide bonds: protein crosslinks built for stress?". Trends in Biochemical Sciences. 36 (4): 229–37. doi:10.1016/j.tibs.2010.09.007. PMID 21055949.
  18. ^ Stark GR, Stein WH, Moore X (1960). "Reactions of the Cyanate Present in Aqueous Urea with Amino Acids and Proteins". J Biol Chem. 235 (11): 3177–3181. doi:10.1016/S0021-9258(20)81332-5.
  19. ^ Van G. Wilson (Ed.) (2004). Sumoylation: Molecular Biology and Biochemistry Archived 2005-02-09 at the Wayback Machine. Horizon Bioscience. ISBN 0-9545232-8-8.
  20. ^ Malakhova OA, Yan M, Malakhov MP, Yuan Y, Ritchie KJ, Kim KI, Peterson LF, Shuai K, Zhang DE (February 2003). "Protein ISGylation modulates the JAK-STAT signaling pathway". Genes & Development. 17 (4): 455–60. doi:10.1101/gad.1056303. PMC 195994. PMID 12600939.
  21. ^ Klareskog L, Rönnelid J, Lundberg K, Padyukov L, Alfredsson L (2008). "Immunity to citrullinated proteins in rheumatoid arthritis". Annual Review of Immunology. 26: 651–75. doi:10.1146/annurev.immunol.26.021607.090244. PMID 18173373.
  22. ^ Brennan DF, Barford D (March 2009). "Eliminylation: a post-translational modification catalyzed by phosphothreonine lyases". Trends in Biochemical Sciences. 34 (3): 108–14. doi:10.1016/j.tibs.2008.11.005. PMID 19233656.
  23. ^ Khoury GA, Baliban RC, Floudas CA (September 2011). "Proteome-wide post-translational modification statistics: frequency analysis and curation of the swiss-prot database". Scientific Reports. 1 (90): 90. Bibcode:2011NatSR...1E..90K. doi:10.1038/srep00090. PMC 3201773. PMID 22034591.
  24. ^ "Proteome-Wide Post-Translational Modification Statistics". selene.princeton.edu. Archived from the original on 2012-08-30. Retrieved 2011-07-22.
  25. ^ a b Lee TY, Huang HD, Hung JH, Huang HY, Yang YS, Wang TH (January 2006). "dbPTM: an information repository of protein post-translational modification". Nucleic Acids Research. 34 (Database issue): D622-7. doi:10.1093/nar/gkj083. PMC 1347446. PMID 16381945.
  26. ^ Hornbeck PV, Zhang B, Murray B, Kornhauser JM, Latham V, Skrzypek E (January 2015). "PhosphoSitePlus, 2014: mutations, PTMs and recalibrations". Nucleic Acids Research. 43 (Database issue): D512-20. doi:10.1093/nar/gku1267. PMC 4383998. PMID 25514926.
  27. ^ a b Goel R, Harsha HC, Pandey A, Prasad TS (February 2012). "Human Protein Reference Database and Human Proteinpedia as resources for phosphoproteome analysis". Molecular BioSystems. 8 (2): 453–63. doi:10.1039/c1mb05340j. PMC 3804167. PMID 22159132.
  28. ^ Sigrist CJ, Cerutti L, de Castro E, Langendijk-Genevaux PS, Bulliard V, Bairoch A, Hulo N (January 2010). "PROSITE, a protein domain database for functional characterization and annotation". Nucleic Acids Research. 38 (Database issue): D161-6. doi:10.1093/nar/gkp885. PMC 2808866. PMID 19858104.
  29. ^ Garavelli JS (January 2003). "The RESID Database of Protein Modifications: 2003 developments". Nucleic Acids Research. 31 (1): 499–501. doi:10.1093/nar/gkg038. PMC 165485. PMID 12520062.
  30. ^ Audagnotto M, Dal Peraro M (2017-03-31). "In silico prediction tools and molecular modeling". Computational and Structural Biotechnology Journal. 15: 307–319. doi:10.1016/j.csbj.2017.03.004. PMC 5397102. PMID 28458782.
  31. ^ Wulff-Fuentes E, Berendt RR, Massman L, Danner L, Malard F, Vora J, Kahsay R, Olivier-Van Stichelen S (January 2021). "The human O-GlcNAcome database and meta-analysis". Scientific Data. 8 (1): 25. Bibcode:2021NatSD...8...25W. doi:10.1038/s41597-021-00810-4. PMC 7820439. PMID 33479245.
  32. ^ Malard F, Wulff-Fuentes E, Berendt RR, Didier G, Olivier-Van Stichelen S (July 2021). "Automatization and self-maintenance of the O-GlcNAcome catalog: a smart scientific database". Database (Oxford). 2021: 1. doi:10.1093/database/baab039. PMC 8288053. PMID 34279596.
  33. ^ Warnecke A, Sandalova T, Achour A, Harris RA (November 2014). "PyTMs: a useful PyMOL plugin for modeling common post-translational modifications". BMC Bioinformatics. 15 (1): 370. doi:10.1186/s12859-014-0370-6. PMC 4256751. PMID 25431162.
  34. ^ Yang Y, Peng X, Ying P, Tian J, Li J, Ke J, Zhu Y, Gong Y, Zou D, Yang N, Wang X, Mei S, Zhong R, Gong J, Chang J, Miao X (January 2019). "AWESOME: a database of SNPs that affect protein post-translational modifications". Nucleic Acids Research. 47 (D1): D874–D880. doi:10.1093/nar/gky821. PMC 6324025. PMID 30215764.
  35. ^ Morris JH, Huang CC, Babbitt PC, Ferrin TE (September 2007). "structureViz: linking Cytoscape and UCSF Chimera". Bioinformatics. 23 (17): 2345–7. doi:10.1093/bioinformatics/btm329. PMID 17623706.
  36. ^ "1tp8 - Proteopedia, life in 3D". www.proteopedia.org.

External linksEdit

(Wayback Machine copy)

(Wayback Machine copy)